Sugiyama H - Search Results

1

Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes.

Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R. Makino H, et al. Among authors: sugiyama h. Diabetes. 1996 Apr;45(4):488-95. doi: 10.2337/diab.45.4.488. Diabetes. 1996. PMID: 8603771

2

Caldesmon isoform associated with phenotypic modulation of mesangial cells.

Okamoto K, Kashihara N, Yamasaki Y, Kanao K, Maeshima Y, Sekikawa T, Sugiyama H, Murakami T, Makino H. Okamoto K, et al. Among authors: sugiyama h. Exp Nephrol. 2000 Jan-Feb;8(1):20-7. doi: 10.1159/000020644. Exp Nephrol. 2000. PMID: 10644879

3

Phenotypic changes of the mesangium in diabetic nephropathy.

Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Shikata K, Nagai R, Ota Z. Makino H, et al. Among authors: sugiyama h. J Diabetes Complications. 1995 Oct-Dec;9(4):282-4. doi: 10.1016/1056-8727(95)80022-7. J Diabetes Complications. 1995. PMID: 8573747

4

Expression of interleukin-8 in human glomerulonephritis.

Sekikawa T, Kashihara N, Maruyama K, Satoh M, Okamoto K, Kanao K, Maeshima Y, Sugiyama H, Yamasaki Y, Makino H. Sekikawa T, et al. Among authors: sugiyama h. Res Commun Mol Pathol Pharmacol. 1998 Feb;99(2):217-24. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9583095

5

Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, Kanao K, Watanabe Y, Kanwar YS, Makino H. Maeshima Y, et al. Among authors: sugiyama h. J Clin Invest. 1998 Jun 1;101(11):2589-97. doi: 10.1172/JCI429. J Clin Invest. 1998. PMID: 9616230 Free PMC article.

6

Regulation of survival and death of mesangial cells by extracellular matrix.

Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H. Sugiyama H, et al. Kidney Int. 1998 Oct;54(4):1188-96. doi: 10.1046/j.1523-1755.1998.00116.x. Kidney Int. 1998. PMID: 9767534 Free article.

7

Apoptosis and extracellular matrix-cell interactions in kidney disease.

Makino H, Sugiyama H, Kashihara N. Makino H, et al. Among authors: sugiyama h. Kidney Int Suppl. 2000 Sep;77:S67-75. Kidney Int Suppl. 2000. PMID: 10997693 Review.

8

Methylprednisolone accelerates the resolution of glomerulonephritis by sensitizing mesangial cells to apoptosis.

Maruyama K, Kashihara N, Yamasaki Y, Sato M, Sugiyama H, Okamoto K, Maeshima Y, Odawara M, Sasaki J, Makino H. Maruyama K, et al. Among authors: sugiyama h. Exp Nephrol. 2001;9(5):317-26. doi: 10.1159/000052627. Exp Nephrol. 2001. PMID: 11549849

9

Intermittent administration of a sustained-release prostacyclin analog ONO-1301 ameliorates renal alterations in a rat type 1 diabetes model.

Yamasaki H, Maeshima Y, Nasu T, Saito D, Tanabe K, Hirokoshi-Kawahara K, Sugiyama H, Sakai Y, Makino H. Yamasaki H, et al. Among authors: sugiyama h. Prostaglandins Leukot Essent Fatty Acids. 2011 Mar-Apr;84(3-4):99-107. doi: 10.1016/j.plefa.2010.11.005. Epub 2010 Dec 21. Prostaglandins Leukot Essent Fatty Acids. 2011. PMID: 21177088

10

[Role of apoptosis in renal injury].

Sugiyama H, Kashihara N, Makino H. Sugiyama H, et al. Nihon Rinsho. 1996 Jul;54(7):1975-81. Nihon Rinsho. 1996. PMID: 8741698 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,737 results

Search Page

Filters